Leanna Lagpacan

522 citations
9 papers · 380 indexed · h-index 6
Topics
HIV/AIDS drug development and treatment (4 papers)HIV Research and Treatment (3 papers)Adenosine and Purinergic Signaling (1 paper)

In The Last Decade

Leanna Lagpacan

9 papers receiving 371 citations

Peers

Leanna Lagpacan
Comparison fields: 5 of 60
  • Molecular Biology 254
  • Infectious Diseases 65
  • Organic Chemistry 63
  • Genetics 49
  • Virology 48
Replace Nicholas Y. Palermo with:
Nicholas Y. Palermo United States
K.A. Walter United States
Joseph Kim United States
Kyle E. Landgraf United States
Brent Graham United Kingdom
David R. Tortolani United States
Stephan Ort Germany
Melanie L. Dart United States
Csaba Szántai-Kis Hungary
Sheri Rogers United States
Leanna Lagpacan relative to Nicholas Y. Palermo United States Nicholas Y. Palermo's profile →
Citations per field
00.5×4.4×
Nicholas Y. Palermo · 1×
Citations per year

Countries citing papers authored by Leanna Lagpacan

Since Specialization
Citations

This map shows the geographic impact of Leanna Lagpacan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leanna Lagpacan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leanna Lagpacan more than expected).

Fields of papers citing papers by Leanna Lagpacan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leanna Lagpacan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leanna Lagpacan. The network helps show where Leanna Lagpacan may publish in the future.

Co-authorship network of co-authors of Leanna Lagpacan

This figure shows the co-authorship network connecting the top 25 collaborators of Leanna Lagpacan. A scholar is included among the top collaborators of Leanna Lagpacan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leanna Lagpacan. Leanna Lagpacan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 20
2 4
3 5
4 119
5 27
6 3
7 7
8 37
9 158

About Leanna Lagpacan

Leanna Lagpacan is a scholar working on Virology, Physiology and Infectious Diseases, having authored 9 papers that have together received 380 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (4 papers), HIV Research and Treatment (3 papers) and Adenosine and Purinergic Signaling (1 paper). The work is most often cited by research in Virology (48 citations), Genetics (49 citations) and Molecular Biology (254 citations). Leanna Lagpacan has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Mary E. McGrath, Dharmaraj Samuel, Achim Brinker, Glen Spraggon, Xueshi Hao, Tetsuo Uno, Jeremy S. Caldwell, Qiong Zhang, Youngha Ryu and Melanie Wong. Their work appears in journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026